The vaccine-autism connection: A public health crisis caused by unethical medical practices and fraudulent science

Annals of Pharmacotherapy

Volumn 45, Issue 10, 2011, Pages 1302-1304

  Flaherty, Dennis K ^a  

^a Robert C Byrd Center for Pharmacy Education   (United States)

Author keywords

MMR vaccine; Regressive autism; Wakefield

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; DISEASE ASSOCIATION; ENTEROCOLITIS; FRAUD; HUMAN; MEASLES; MEDICAL ETHICS; MEDICAL PRACTICE; MUMPS; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RUBELLA; VACCINATION;

ATTITUDE TO HEALTH; AUTISTIC DISORDER; CHILD; EVIDENCE-BASED MEDICINE; HEALTH PROMOTION; HUMANS; PARENTS; PATIENT EDUCATION AS TOPIC; PROFESSIONAL MISCONDUCT; SCIENTIFIC MISCONDUCT; TREATMENT REFUSAL; VACCINES;

EID: 80053933087     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q318     Document Type: Article

References (31)

1. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
2. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev 2000;19:265-83.
3. Health Protection Agency. Completed primary course at two years of age: England and Wales, 1966-1977, England only 1978 onwards. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/11 95733819251 (accessed 2011 Apr 3).
4. Health Protection Agency. Confirmed cases of measles, mumps and rubella 1996-2009. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb_C/1195733833790 (accessed 2011 May 4).
5. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15:265-302.
6. National, state and urban area vaccination coverage levels among children aged 19-35 months-United States, 1998. MMWR Morb Mortal Wkly Rep 2000;49:1-26 www.cdc.gov/mmwr/preview/mmwrhtml/mm4926a1. htm (accessed 2011 Jun 14).
7. National, state and urban area vaccination coverage among children aged 19-35 months-United States, 2003. MMWR Morb Mortal Wkly Rep2003;53:658-61 www.cdc.gov/mmwr/preview/mmwrhtml/mm5329a3. htm (accessed 2011 Jun 14).
8. National, state and urban area vaccination coverage among children aged 19-35 months-United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:921-6 www.cdc.gov/mmwr/preview/mmwrhtml/mm5833a3. htm (accessed 2011 Jun 16).
9. Offit PA. Autism's false prophets: bad science, risky medicine, and the search for a cure. New York, NY: Columbia University Press, 2008:24.
10. DeStefano F, Thompson WW. MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines 2004;3:19-22.
11. DeWilde S, Carey IM, Richards N, Hilton SR, Cook DG. Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract 2001;51:226-7.
12. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001;19:3632-3635.
13. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-1482.
14. Makela A, Nuorti JP, Peltola H. Neurological disorders after measlesmumps-rubella vaccination. Pediatrics 2002;110:957-963.
15. Takahashi H, Suzumura S, Shirakizawa F, et al. An epidemiological study on Japanese autism concerning routine childhood immunization history. Jpn J Infect Dis 2003;56:114-117.
16. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-2029.
17. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA 2001;285:1183-1185.
18. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-463.
19. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteenyear prospective follow-up. Pediatr Infect Dis J 2000;19:1127-1134.
20. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351:1327-8.
21. Boodman S. Inside the vaccine-autism scare. www.washingtonpost. com/wp-dyn/content/article/2011/01/14/AR2011011407024.html (accessed 2011 Jun 21).
22. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics 2010;125:654-9.
23. Deer B. Secrets of the MMR scare. The Lancet's two days to bury bad news. BMJ 2011;342:c7001.
24. Deer B. How the case against the MMR vaccine was fixed. BMJ 2011; 342:c5347.
25. Horton R. A statement by the editors of The Lancet. Lancet 2004;363: 820-1.
26. Murch SH, Anthony A, Casson DH, et al. Retraction of an interpretation. Lancet 2004;363:750.
27. General Medical Council. Fitness to practise panel hearing 28 January 2010. http:// www.casewatch.org/foreign/wakefield/gmc_findings.pdf (accessed 2011 May 11).
28. General Medical Council. Determination on serious professional misconduct (SPM) and sanction. http:// www.gmc-uk.org/Wakefield_SPM_ and_SANCTION.pdf_32595267.pdf (accessed 2011 May 12).
29. Retraction-Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010;375:445.
30. Godlee F, Smith J, Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ 2011;342:c7452.
31. Deer B. Secrets of the MMR scare. How the vaccine crisis was meant to make money. BMJ 2011;342:c5258.